May 26, 2016 11:14 AM ET

Healthcare Equipment and Supplies

Company Overview of AxoGen, Inc.

Company Overview

AxoGen, Inc. operates as a medical technology company. It offers a portfolio of nerve repair solutions for various surgical peripheral nerve repair needs. The company’s surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf human nerve allograft for bridging nerve discontinuities without the comorbidities associated with another surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue atta...

13631 Progress Boulevard

Suite 400

Alachua, FL 32615

United States

113 Employees

Phone:

386-462-6800

Fax:

386-462-6801

Key Executives for AxoGen, Inc.

Chief Executive Officer, President and Director
Age: 53
Total Annual Compensation: $511.0K
Senior Vice President of Business Development, General Counsel and Director
Age: 53
Total Annual Compensation: $303.0K
Senior Vice President of Sales
Age: 57
Total Annual Compensation: $374.3K
Compensation as of Fiscal Year 2015.

AxoGen, Inc. Key Developments

AxoGen, Inc. - Shareholder/Analyst Call

Annual meeting of shareholders

AxoGen, Inc. Appoints Kevin Leach as Vice President of Marketing

AxoGen, Inc. has announced the appointment of Kevin Leach as vice president of marketing. Mr. Leach will report directly to Karen Zaderej, President and CEO and will be responsible for AxoGen's global marketing strategies and functions. Prior to joining AxoGen, Mr. Leach was the vice president, Global Knee Marketing of Stryker Corporation, a medical technology company offering innovative products and services in Orthopaedics, Medical and Surgical, Neurotechnology and Spine.

AxoGen, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2016; Re-Affirms Earnings Guidance for the Full Year of Fiscal 2016

AxoGen, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2016. For the quarter, the company announced revenues of $8,111,759 compared to $4,951,316 for the same period a year ago. Loss from operations was $2,622,804 compared to $2,543,704 for the same period a year ago. Net loss was $3,676,091 compared to $3,575,201 for the same period a year ago. Loss per common share basic and diluted was $0.12 compared to $0.16 for the same period a year ago. Net cash used for operating activities was $4,609,107 compared to $2,513,718 for the same period a year ago. Purchase of property and equipment was $402,927 compared to $6,288 for the same period a year ago. Acquisition of intangible assets was $85,416 compared to $32,051 for the same period a year ago. The company re-affirms earnings guidance for the full year of fiscal 2016. Management is reaffirming that full year 2016 revenue will approach $39 million, and is now increasing the full year 2016 gross margin outlook from the previously stated high 70% range, to approaching 80%.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AxoGen, Inc., please visit www.axogeninc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.